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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A362perform a quantitative proteomics approach to identify and quantify
those proteins released from normal (N) and OA human articular car-
tilages capable of predicting the early stage of hip and knee OA.
Methods: Tissue explants were obtained from the dissection of 4 N and
4 OA cartilages, both from 2 femoral heads and 2 tibial condyles. Among
the OA samples, we differentiated the wounded zones (WZOA) from
those corresponding to the area adjacent to the lesion, or unwounded
zones (UWOA). Cartilage shavings from each donor were cut into 6 mm
discs and three discs/donor were placed into 96-well plates and cul-
tured during 6 days. The conditioned media from each condition (N,
WZOA and UWOA) were collected and their proteins were digested
with trypsin. The resulting peptides were labelled with different iso-
baric tags using the iTRAQ reagents (ABSciex). Then, labelled peptides
from the different conditions were mixed, desalted and separated by
liquid chromatography (LC). The resulting fractions were grouped and
resolved by reversed-phase nano-LC coupled to mass spectrometry
(MS). The identiﬁcation and relative quantiﬁcation of the proteins was
carried out with Protein Pilot 3.0 software.
Results: Globally we were able to identify 186 proteins released from
the cartilage explants. After statistical analysis we found secreted pro-
teins showing differences in abundance (0.7 ratio 1.3, p 0.05)
between the different OA zones (WZOA and UWOA) and N samples
from the different joints. We classiﬁed them into 3 sets of proteins: a
ﬁrst group of proteins modulated speciﬁcally in UWOA sample (early
OA biomarkers); a second group of proteins altered only in WZOA
samples (late OA biomarkers), and ﬁnally a third groupmodiﬁed in both
OA zones (progression biomarkers). Some of these modulated proteins
are common early and progression biomarkers for both hip and knee OA
(table1). Furthermore, we also identiﬁed that the release of cartilage
intermediate layer protein 1 (CILP-1), a protein involved in cartilage
scaffolding, is increased in UWOA from hip OA cartilage but not in
UWOA from knee OA, being a possible early speciﬁc biomarker for hip
OA. This speciﬁc modulation was conﬁrmed by Real-time PCR and
western blot in other human cartilage samples (n¼3).
Conclusions: We describe a novel panel of cartilage-secreted proteins
with potential biomarker value. Interestingly, we have identiﬁed a
speciﬁc protein, which speciﬁcally indicates hip OA onset. This protein
is now being explored in biological ﬂuids (synovial ﬂuid and serum) for
the development of early diagnosis and/or anti-OA therapy monitoring
strategies.Table 1
A panel of different type of potential protein biomarkers of hip OA(H) and knee OA(K) is listed in the table. Proteins showing a gradual increase among OA samples is indicated
as early and progression biomarkers. CLIP-1 speciﬁcally indicates hip OA.
Protein Name Uniprot symbol Joint peptides (95%) Ratio UWOA/N p value Ratio WZOA/N p value OA biomarker type
Pigment epithelium-derived factor PEDF H 25 2,35 0,00 4,73 0,00 Early and progression
K 32 2,31 0,00 3,16 0,00
Tenascin TENA H 60 2,99 0,00 5,03 0,00 Early and progression
K 65 1,68 0,00 6,01 0,00
Tenascin-X TENX H 28 3,21 0,00 6,84 0,00 Early and progression
K 52 1,34 0,02 2,38 0,00
Tetranection TNT H 15 2,63 0,00 3,68 0,00 Early and progression
K 16 1,96 0,01 3,52 0,00
Transforming growth factor-beta
included protein lg-h3
BGH3 H 24 5,34 0,00 6,12 0,00 Early and progression
K 23 1,57 0,00 3,55 0,00
Vimentin VIM H 22 3,69 0,00 5,13 0,00 Early and progression
K 30 1,40 0,00 4,85 0,00
Cartilage intermediate layer protein 1 CILP-1 H 142 2,27 0,00 1,02 0,83 Early
K 102 1,27 0,00 1,06 0,46 -595
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Purpose: Hyaluronic acid (HA), lubricin, and phospholipids contribute
independently or together to the boundary lubrication of articular
joints that is provided by synovial ﬂuid (SF). In our present study wefocused on the two widespread joint diseases, osteoarthritis (OA) and
rheumatoid arthritis (RA). With use of sophisticated analytical methods
our study aimed to quantify the various molecular weight (MW) forms
of HA, lubricin, and all phospholipid species. Notably, we quantiﬁed
these lubricants for the ﬁrst time in parallel in knee SF from cohorts of
healthy donors, patients with early (eOA) or late (lOA) stage osteo-
arthritis, and patients with active RA.
Methods: Only patients fulﬁlling the inclusion criteria were included in
the study. This study was approved by the ethical review committee of
the Faculty of Medicine (Justus-Liebig-University of Giessen, Germany).
Cell- and cellular debris-free SF samples from unaffected controls, eOA,
lOA, and RA were used for this study. HA and lubricin levels were
measured by sandwich enzyme-linked immunosorbent assay (ELISA).
Electrospray ionization tandem mass spectrometry was used to quan-
tify phospholipid species, and fatty acids (FAs) were analyzed by gas
chromatography, coupled with mass spectrometry. The MW dis-
tribution of HA was determined by horizontal agarose gel electro-
phoresis followed by densitometry. One way ANOVA and Tukey’s
honestly signiﬁcant difference procedure were applied to determine
statistical signiﬁcant differences. P values of less than 0.05 were con-
sidered to be statistically signiﬁcant.
Results: We provide a novel, comprehensive overview of all lubricants
present in normal, OA and RA SF, namely HA, lubricin, and phospholi-
pids. Compared with control SF, the concentrations of HA and lubricin
were signiﬁcantly lower in eOA, lOA and RA SF, whereas those of
phospholipids were higher. Moreover, compared with control SF, the
MW distribution of HA shifted towards the lower range of below 1.1
MDa in eOA, lOA and RA SF. Notably, positive correlations were
observed in eOA SF between the concentrations of HA and lubricin, and
in lOA SF between the levels of HA and phospholipids. Moreover, in eOA
SF an elevated percentage of degraded HA was associated with lower
levels of lubricin. Remarkably, we noted distinct alterations between
cohorts with respect to the relative distribution of phospholipid species
and the degree of FA saturation and chain lengths of FAs.
Conclusions: This investigation reports for the ﬁrst time a compre-
hensive overview of all lubricants present in human SF, namely HA,
lubricin, and phospholipids. The levels, composition, and MW dis-
tribution of these lubricants vary with widespread joint diseases and
stage of OA. Thus, our study provides the framework to develop new
and optimal compounded lubricants able to reduce joint destruction.596
TARGETED PROTEOMICS OF HIP ARTICULAR CARTILAGE IN OA AND
FRACTURE PATIENTS
P. Onnerfjord, A. Khabut, S. Hosseininia, L. Dahlberg. Clinical Sci., Lund,
Sweden
Purpose: We have previously used quantitative proteomics for a
detailed study of different normal cartilage subtypes to increase our
knowledge of structure in relation to biology and function. In this work
we studied changes in protein abundance in hip cartilage between
osteoarthritis (OA) and fracture patients by using the increased sensi-
tivity of targeted proteomics technology.
Methods: Site matched femoral head articular cartilage from both OA
joint replacement patients selecting the macroscopically normal tissue
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A363furthest away from the OA lesion (n¼10) and fracture patients (refer-
ence cartilage, n¼10) were examined. Femoral heads were obtained
from surgery of total hip replacement due to OA and femoral neck
fracture due to fragility. Our gel-free proteomics approach include
cartilage powderization, tissue extraction, digestion by trypsin and
reversed phase separations (nano-LC) coupled to tandem mass spec-
trometry for the quantiﬁcation of peptides. We used a targeted multi-
plex approach using single reaction monitoring (SRM) with 135
optimized SRM assays representing 35 extracellular matrix proteins.
The combination of a peptide precursor mass together with a fragment
mass (Q1/Q3) is called a transition and we used 3-5 transitions for each
targeted peptide. Duplicate injections for each sample were made and
relative quantiﬁcation was performed by SRM with identiﬁcations
being conﬁrmed using synthetic peptide standards for comparison of
retention times and transitions. Skyline software (MacCoss Lab) was
used to identify peptides and quantify peak intensities.
Results: Data shown are the averaged peak intensities of ten biological
samples with two technical replicates of each sample where the tech-
nical variation is small (not shown) in comparison to the biological
variation (error bars). The data showed 4-fold increased levels of
tenascin X and mimecan peptides (ﬁg 1 A-B), in the osteoarthritic car-
tilages compared to fracture patients. In contrast, the protein throm-
bospondin 1 was less abundant in the OA samples. However, most
targeted proteins were not signiﬁcantly different in protein levels e.g.
COMP and chondroadherin (ﬁg 1 C-D).
Conclusions: This work reports how a multiplexed targeted mass
spectrometric approach can be used to study differences in protein
levels of femoral articular cartilage from OA vs fracture patients. Most
protein levels were not found to be signiﬁcantly different. However, we
identiﬁed protein targets that were present at higher (e.g. mimecan and
tenascin) or lower (e.g. thrombospondin 1) levels in the OA cartilage.
The increased levels of tenascin in OA cartilage could be an attempt of
cartilage repair.
Figure1. SRMdata showing total peak areaof all transitions foreachpeptide,
representing various extracellular matrix proteins representing higher (A,
B) and unchanged levels (C, D) of targeted peptides (n¼10, P¼0.05).
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Purpose: Osteoarthritis (OA) is a joint disease characterized by joint
homeostatic alterations leading to progressive cartilage degradation,
subchondral bone sclerosis and joint destruction. Maintenance and
restoration of joint cartilage andbone structures depend on chondrocytes
and osteblasts, both arising from commonprogenitormesenchymal stem
cells (MSCs). Thus, MSCs have become interesting players in the ﬁeld of
regenerativemedicineboth to replace injured tissues or to promote tissue
repair. However, molecularmechanisms governing their properties in OA
remain largely unknown. Similarly, it is also unknown whether the bio-
logical niche of MSCs determines their different potential.
In order to better understand the role of MSCs in health and disease, we
aimed to describe, by quantitative proteomic analysis, the protein
expression proﬁle of MSCs in different sublocalizations in OA and non-
OA subjects.Methods:MSCswere obtained from subchondral bone (SB) cartilage (C)
and bone marrow(BM) sublocalizations of a hip OA patient (CX) and a
control donor (subcapital fracture) (SF). Cells were isolated, cultured
and expanded.Total protein content was isolated dried in air and then
re-suspended in 25 ml Dissolution Buffer. Protein concentrations were
determined by Bradford assay (Sigma-Aldrich, St. Louis, MO, USA).
Equal amount of total protein for each condition were subjected to in-
solution digestion, followed by iTRAQ labelling according to manu-
facturer instructions (ABSciex, Foster city, CA, USA). The samples were
labelled as follows: CX-SB(113); CX-C(114); CX-BM(115) and SF-SB(116),
, SF-C(117); SF-BM(118). Two samples were additionally labelled CX-
BM(119) and SF-BM(119) as internal contol. The samples were then
mixed together and desalted with home-made C-18 Stage-tips (Rap-
psilber andMann, 2003). Reverse Phase peptide separationwasmade in
a LC system (Agilent Technologies, Santa Clara, CA, USA). Fractions were
again separated in a nanoLC system (Tempo, Eksigent) automatically
deposited on a MALDI plate and analyzed by MSMS in a 4800 MALDI-
TOF/TOF system (ABSciex).
Relative quantitative analysis was done using ProteinPilot software
(ABSciex) that uses the Paragon™ Algorithm for protein identiﬁcation
and quantiﬁcation. Only proteins identiﬁed with at least 95% con-
ﬁdence, a Prot Score (protein conﬁdence measure) of at least 1.3, a p-
value  0.05 and ratio (s1) were considered as modulated. Ontological
analysis to determine biological annotations or combinations of anno-
tations signiﬁcantly associated to the list of modulated proteins were
analyzed with GeneCodis3 http://genecodis.cnb.csic.es).
Results: A total of 828 proteins were identiﬁed with high conﬁdence,
153 of themwith p values >0.05. 9 out of 153 proteins were common to
SB-MSCs, C-MSCs and BM-MSCs while 38, 25 and 27 respectively were
unique to these sublocalizations. Comparison between OA and non-OA
subjects revealed the upregulation of 67 proteins and the down-
regulation of 86 proteins in OA-MSCs. (Figure) Ontological classiﬁcation
of these proteins revealed the enrichment in cytoplasmic and cytosolic
proteins. OA upregulated proteins mainly corresponding to: carbohy-
drate metabolism and aging biological processes, were enriched BM-
MSCs. Cell proliferation, carbohydrate metabolism, signal transduction
and protein folding in SB-MSCs; and Glycolysis/Gluconeogenesis and
Protein processing in cartilage MSCs. Downregulated proteins were
related with carbohydrate metabolism and cell death in SB and trans-
lation, protein folding, developmental maturation in Cartilage-MSCs.
Conclusions: This study generates an initial proteome reference map of
MSCs from OA and non-OA of three different sublocalizations, which
will be valuable to functionally validate the role of differentially regu-
lated proteins to better understand the underlying mechanism of MSCs
differentiation.
